A systematic review of oral assessment instruments: What can we recommend to practitioners in children's and young people's cancer care?

Cancer Nursing

Volumn 33, Issue 4, 2010, Pages

  Gibson, Faith ^a   Auld, Elizabeth M ^b   Bryan, Gemma ^c   Coulson, Suzanne ^d   Craig, Jean V ^e   Glenny, Anne Marie ^f  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b Manchester Children's Hospital   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^e UNIVERSITY OF LIVERPOOL   (United Kingdom)

^f UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Adolescence; Children; Mucositis measurement; Oral mucositis; Review; Systematic

Indexed keywords

ADULT; ARTICLE; CHILD; CLINICAL ASSESSMENT TOOL; DIET; GINGIVA; HUMAN; LIP; MOUTH DISEASE; MUCOSA; MUCOSA INFLAMMATION; ORAL ASSESSMENT GUIDE; PAIN; PALATE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RELIABILITY; SALIVA; SELF CARE; SWALLOWING; TASTE; TONGUE; TOOTH; VALIDITY; VOICE; XEROSTOMIA; ADOLESCENT; COMPLICATION; EVIDENCE BASED PRACTICE; METHODOLOGY; NEOPLASM; NURSING; NURSING ASSESSMENT; ONCOLOGY NURSING; PROCEDURES; QUALITY CONTROL; REPRODUCIBILITY; STANDARDS; STOMATITIS; UNITED KINGDOM; YOUNG ADULT;

ADOLESCENT; BENCHMARKING; CHILD; DIAGNOSIS, ORAL; EVIDENCE-BASED PRACTICE; GREAT BRITAIN; HUMANS; NEOPLASMS; NURSING ASSESSMENT; ONCOLOGIC NURSING; PRACTICE GUIDELINES AS TOPIC; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; STOMATITIS; YOUNG ADULT; ONCOLOGY NURSING;

EID: 77954145889     PISSN: 0162220X     EISSN: None     Source Type: Journal    
DOI: 10.1097/NCC.0b013e3181cb40c0     Document Type: Article

References (103)

1. Gatta G, Capocaccia R, Coleman MP, Ries LA, Berrino F. Childhood cancer survival in Europe and the United States. Cancer. 2002;95(8): 1767-1772.
2. Miller M, Kearney N. Oral care for patients with cancer: a review of the literature. Cancer Nurs. 2001;24(4):241-254.
3. Epstein JB, Emerton S, Kolbinson DA, et al. Quality of life and oral function following radiotherapy for head and neck cancer. Head Neck. 1999;21(1):1-11.
4. Fulton JS, Middleton GJ, McPhail JT. Management of oral complications. Semin Oncol Nurs. 2002;18(1):28-35.
5. Sonis S. Oral complications of cancer therapy. In: De Vita V, Hellman S, Rosenberg S, eds. Principles and Practices of Oncology. Philadelphia, PA: Lippincott-Raven; 1993:2385-2394.
6. Parulekar W, Mackenzie R, Bjarnason G, Jordan RC. Scoring oral mucositis. Oral Oncol. 1998;34(1):63-71.
7. Eilers J, Million R. Prevention and management of oral mucositis in patients with cancer. Semin Oncol Nurs. 2007;23(3):201-212.
8. Cheng KK, Molassiotis A, Chang AM. An oral care protocol intervention to prevent chemotherapy-induced oral mucositis in paediatric cancer patients: a pilot study. Eur J Oncol Nurs. 2002;6(2):66-73.
9. Eilers J, Epstein JB. Assessment and measurement of oral mucositis. Semin Oncol Nurs. 2004;20(1):22-29.
10. Brown CG, Wingard J. Clinical consequences of oral mucositis. Semin Oncol Nurs. 2004;20(1):16-21.
11. Collins JJ, Byrnes ME, Dunkel IJ, et al. The measurement of symptoms in children with cancer. J Pain Symptom Manage. 2000;19(5):363-377.
12. Glenny AM, Gibson F, Auld E, et al. A survey of current practice with regard to oral care for children being treated for cancer. Eur J Cancer. 2004;40(8):1217-1224. (Pubitemid 38526341)
13. Craig J, Symthe R. The Evidence-Based Practice Manual for Nurses. 2nd ed. Edinburgh, Scotland: Churchill Livingstone Elsevier; 2006.
14. Quinn B, Potting CM, Stone R, et al. Guidelines for the assessment of oral mucositis in adult chemotherapy, radiotherapy and haematopoietic stem cell transplant patients. Eur J Cancer. 2008;44(1):61-72.
15. Scottish Intercollegiate Guidelines Network (SIGN). A Guideline Developers Handbook. Edinburgh, Scotland: SIGN; 2002.
16. Children's Cancer and Leukaemia Group. http.www.ukccsg.org/ researchandtreatment. Accessed January 14, 2010.
17. Madeya ML. Oral complications from cancer therapy: part 2Vnursing implications for assessment and treatment. Oncol Nurs Forum. 1996;23(5):808-819.
18. Browman GP, Levine MN, Hodson DI, et al. The Head and Neck Radiotherapy Questionnaire: a morbidity/quality-of-life instrument for clinical trials of radiation therapy in locally advanced head and neck cancer. J Clin Oncol. 1993;11(5):863-872.
19. Cowen D, Tardieu C, Schubert M, et al. Low energy helium-neon laser in the prevention of oral mucositis in patients undergoing bone marrow transplant: results of a double blind randomized trial. Int J Radiat Oncol Biol Phys. 1997;38(4):697-703.
20. Dodd MJ, Dibble SL, Miaskowski C, et al. Randomized clinical trial of the effectiveness of 3 commonly used mouthwashes to treat chemotherapy-induced mucositis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90(1):39-47.
21. John M. Grading of chemoradiation toxicity, chapter 42. In: John M, Flam M, Legha S, Philips T, eds. Chemoradiation: An integrated Approach to Cancer Treatment. Philadelphia, PA: Lea and Febiger; 1993: 601-606.
22. Melzack R. The short-form McGill Pain Questionnaire. Pain. 1987;30(2):191-197.
23. Wilkes JD. Prevention and treatment of oral mucositis following cancer chemotherapy. Semin Oncol. 1998;25(5):538-551.
24. DeWalt EM. Effect of timed hygienic measures on oral mucosa in a group of elderly subjects. Nurs Res. 1975;24(2):104-108.
25. Schweiger JL, Lang JW, Schweiger JW. Oral assessment: how to do it. Am J Nurs. 1980;80(4):654-657.
26. Turner G. Oral care for patients who are terminally ill. Nurs Stand. 1994;8(41):49-54.
27. Harris DJ, Knobf MT. Assessing and managing chemotherapy-induced mucositis pain. Clin J Oncol Nurs. 2004;8(6):622-628.
28. Rosenthal DI, Mendoza TR, Chambers MS, et al. Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module. Head Neck. 2007;29(10):923-931.
29. Fanning SR, Rybicki L, Kalaycio M, et al. Severe mucositis is associated with reduced survival after autologous stem cell transplantation for lymphoid malignancies. Br J Haematol. 2006;135(3):374-381.
30. Aquino VM, Harvey AR, Garvin JH, et al. A double-blind randomized placebo-controlled study of oral glutamine in the prevention of mucositis in children undergoing hematopoietic stem cell transplantation: a pediatric blood and marrow transplant consortium study. Bone Marrow Transplant. 2005;36(7):611-616.
31. Beck S. Impact of a systematic oral care protocol on stomatitis after chemotherapy. Cancer Nurs. 1979;2(3):185-199.
32. Bentzen SM, Saunders MI, Dische S, Bond SJ. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radio-biology as deduced from the CHART trial. Radiother Oncol. 2001;60(2):123-135.
33. Bolwell BJ, Kalaycio M, Sobecks R, et al. A multivariable analysis of factors influencing mucositis after autologous progenitor cell transplantation. Bone Marrow Transplant. 2002;30(9):587-591.
34. Bruya MA, Madeira NP. Stomatitis after chemotherapy. Am J Nurs. 1975;75(8):1349-1352.
35. Byfield J, Frankel S, Sharp T, Hornbeck C, Callipari F. Phase I and pharmacologic study of 72 hour infused 5-fluorouracil and hyper-fractionated cyclical radiation. Int J Radiat Oncol Biol Phys. 1985;11(4):791-800.
36. Turhal NS, Erdal S, Karacay S. Efficacy of treatment to relieve mucositis-induced discomfort. Support Care Cancer. 2000;8(1):55-58.
37. Carl W, Emrich LS. Management of oral mucositis during local radiation and systemic chemotherapy: a study of 98 patients. J Prosthet Dent. 1991;66(3):361-369.
38. Chapko MK, Syrjala KL, Bush N, Jedlow C, Yanke MR. Development of a behavioral measure of mouth pain, nausea, and wellness for patients receiving radiation and chemotherapy. J Pain Symptom Manage. 1991;6(1):15-23.
39. Chen CF, Wang RH, Cheng SN, Chang YC. Assessment of chemotherapy-induced oral complications in children with cancer. J Pediatr Oncol Nurs. 2004;21(1):33-39.
40. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31(5):1341-1346.
41. Trotti A, Byhardt R, Stetz J, et al. Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys. 2000;47(1):13-47.
42. Cancer Therapy Evaluation Program. Common terminology criteria for adverse events. Version 3. http://ctep.cancer.gov/protocolDevelopment/ electronic-applications/docs/ctcaev3.pdf. Accessed January 14, 2010.
43. Cancer Therapy Evaluation Program. Common terminology criteria for adverse events (CTCAE). http://evs.nci.gov/ftpl/CTCAE/CTCAE-4.02-2009-09-15- QuickReference-5x7.pdf. Accessed January 14, 2010.
44. Damon LE, Johnston LJ, Ries CA, et al. Treatment of acute leukemia with idarubicin, etoposide and cytarabine (IDEA). A randomized study of etoposide schedule. Cancer Chemother Pharmacol. 2004; 53(6):468-474.
45. Dibble SS, Shiba G, MacPhail L, Dodd M. MacDibbs Mouth Assessment. A new tool to evaluate mucositis in the radiation therapy patient. Cancer Pract. 1996;32B(6):381-387.
46. Donnelly JP, Muus P, Schattenberg A, De Witte T, Horrevorts A, DePauw B. A scheme for daily monitoring of oral mucositis in allogeneic BMT recipients. Bone Marrow Transplant. 1992;9(6):409-413.
47. Dudjak LA. Mouth care for mucositis due to radiation therapy. Cancer Nurs. 1987;10(3):131-140.
48. Eilers J, Berger AM, Petersen MC. Development, testing, and application of the oral assessment guide. Oncol Nurs Forum. 1988; 15(3):325-330.
49. Ferretti GA, Ash RC, Brown AT, Parr MD, Romond EH, Lillich TT. Control of oral mucositis and candidiasis in marrow transplantation: a prospective, double-blind trial of chlorhexidine digluconate oral rinse. Bone Marrow Transplant. 1988;3(5):483-493.
50. Gandemer V, Le Deley MC, Dollfus C, et al. Multicenter randomized trial of chewing gum for preventing oral mucositis in children receiving chemotherapy. J Pediatr Hematol Oncol. 2007;29(2):86-94.
51. Gibson F, Cargill J, Allison J, et al. Establishing content validity of the oral assessment guide in children and young people. Eur J Cancer. 2006;42(12):1817-1825.
52. Harris DJ. Cancer treatment induced mucositis pain: strategies for assessment and management. Ther Clin Risk Manage. 2006; 2(3):251-258.
53. Hickey AJ, Toth BB, Lindquist SB. Effect of intravenous hyper-alimentation and oral care on the development of oral stomatitis during cancer chemotherapy. J Prosthet Dent. 1982;47(2):188-193.
54. Kushner JA, Lawrence HP, Shoval I, et al. Development and validation of a Patient-Reported Oral Mucositis Symptom (PROMS) scale. J Can Dent Assoc. 2008;74(1):59.
55. Lievens Y, Haustermans K, Van den Weyngaert D, et al. Does sucralfate reduce the acute side-effects in head and neck cancer treated with radiotherapy? A double-blind randomized trial. Radiother Oncol. 1998;47(2):149-153.
56. Lindquist SF, Hickey AJ, Drane JB. Effect of oral hygiene on stomatitis in patients receiving cancer chemotherapy. J Prosthet Dent. 1978;40(3):312-314.
57. Maciejewski B, Skladowski K, Pilecki B, et al. Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity. Radiother Oncol. 1996;40(2):137-145.
58. McGuire DB, Altomonte V, Peterson DE, Wingard JR, Jones RJ, Grochow LB. Patterns of mucositis and pain in patients receiving preparative chemotherapy and bone marrow transplantation. Oncol Nurs Forum. 1993;20(10):1493-1502.
59. McGuire DB, Peterson DE, Muller S, Owen DC, Slemmons MF, Schubert MM. The 20 item oral mucositis index: reliability and validity in bone marrow and stem cell transplant patients. Cancer Invest. 2002; 20(7-8):893-903.
60. National Institutes of Health. Common toxicity criteria. Investigator's Handbook. A Manual for Participants in Clinical Trials of Investigational Agents. Sponsored by the Division of Cancer Treatment, National Cancer Institute; 1993. http://ctep.info.nih.gov/protocolDevelopment/electronic- applications/ctc.htm#ctc-v40. Accessed January 2010.
61. Öhrn KE, Wahlin YB, Sjoden PO. Oral status during radiotherapy and chemotherapy: a descriptive study of patient experiences and the occurrence of oral complications. Support Care Cancer. 2001;9(4):247-257.
62. Passos JY, Brand LM. Effects of agents used for oral hygiene. Nurs Res. 1966;15(3):196-202.
63. Pitten FA, Kiefer T, Buth C, Doelken G, Kramer A. Do cancer patients with chemotherapy-induced leukopenia benefit from an antiseptic chlorhexidine-based oral rinse? A double-blind, block-randomized, controlled study. J Hosp Infect. 2003;53(4):283-291.
64. Potting CM, Blijlevens NA, Donnelly JP, Feuth T, Van Achterberg T. A scoring system for the assessment of oral mucositis in daily nursing practice. Eur J Cancer Care (Engl). 2006;15(3):228-234.
65. Raether D, Walker PO, Bostrum B, Weisdorf D. Effectiveness of oral chlorhexidine for reducing stomatitis in a pediatric bone marrow transplant population. Pediatr Dent. 1989;11(1):37-42.
66. Schubert MM, Williams BE, Lloid ME, Donaldson G, Chapko MK. Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation. Development of an oral mucositis index. Cancer. 1992;69(10):2469-2477.
67. Kolbinson DA, Schubert MM, Flournoy N, Truelove EL. Early oral changes following bone marrow transplantation. Oral Surg Oral Med Oral Pathol. 1988;66(1):130-138.
68. Seto BG, Kim M, Wolinsky L, Mito RS, Champlin R. Oral mucositis in patients undergoing bone marrow transplantation. Oral Surg Oral Med Oral Pathol. 1985;60(5):493-497.
69. Sonis ST, Eilers JP, Epstein JB, et al. Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group. Cancer. 1999;85(10):2103-2113.
70. Spijkervet FK, van Saene HK, Panders AK, Vermey A, Mehta DM. Scoring irradiation mucositis in head and neck cancer patients. J Oral Pathol Med. 1989;18(3):167-171.
71. Stiff PJ, Erder H, Bensinger WI, et al. Reliability and validity of a patient self-administered daily questionnaire to assess impact of oral mucositis (OM) on pain and daily functioning in patients undergoing autologous hematopoietic stem cell transplantation (HSCT). Bone Marrow Transplant. 2006;37(4):393-401.
72. Sung L, Tomlinson GA, Greenberg ML, et al. Validation of the oral mucositis assessment scale in pediatric cancer. Pediatr Blood Cancer. 2006;49(2):149-153.
73. Tanner NS, Stamford IF, Bennett A. Plasma prostaglandins in mucositis due to radiotherapy and chemotherapy for head and neck cancer. Br J Cancer. 1981;43(6):767-771.
74. Tardieu C, Cowen D, Thirion X, Franquin JC. Quantitative scale of oral mucositis associated with autologous bone marrow transplantation. Eur J Cancer B Oral Oncol. 1996;32B(6):381-387.
75. Van der Schueren E, Van den Bogaert W, Ang KK. Radiotherapy with multiple fractions per day. In: Steel GG, Adams GE, Peckham MJ, eds. The Biological Basis of Radiotherapy. Oxford: Elsevier; 1983.
76. Van Drimmelen J, Rollins HF. Evaluation of a commonly used oral hygiene agent. Nurs Res. 1969;18(4):327-332.
77. Development of a staging system for chemotherapy-induced stomatitis. Western Consortium for Cancer Nursing Research. Cancer Nurs. 1991;14(1):6-12.
78. Olson K, Hanson J, Hamilton J, et al. Assessing the reliability and validity of the revised WCCNR stomatitis staging system for cancer induced stomatitis. Can Oncol Nurs J. 2004;4(3):168-174.
79. Walsh LJ, Hill G, Seymour G, Roberts A. A scoring system for the quantitative evaluation of oral mucositis during bone marrow transplantation. Spec Care Dentist. 1990;10(6):190-195.
80. Weisdorf DJ, Bostrom B, Raether D, et al. Oropharyngeal mucositis complicating bone marrow transplantation: prognostic factors and the effect of chlorhexidine mouth rinse. Bone Marrow Transplant. 1989;4(1):89-95.
81. World Health Organization (WHO). WHO Handbook for Reporting Results of Cancer Treatment. Geneva, Switzerland: WHO; 1977.
82. World Health Organization (WHO). WHO Handbook for Reporting Results of Cancer Treatment. Geneva, Switzerland: WHO; 1979.
83. World Health Organisation (WHO). Oral Health Surveys: Basic Methods. Vol 3. Geneva, Switzerland: WHO; 1986.
84. Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore. 1994;23(2):129-138.
85. Devins GM, Orme CM, Costello CG, et al. Measuring depressive symptoms in illness populations: reliability and factorial composition of the Center for Epidemiologic Studies Depression (CES-D) scale. Psychol Health. 1988;2:139-156.
86. Streiner D. Health Measurement Scales: A Practical Guide to Their Development and Their Use. Vol 2. Oxford: Oxford University Press; 1996.
87. Bowling A. Measuring Disease. Vol 2. Buckingham, England: Open University Press; 2001.
88. Nolan M. Measuring Patient Outcomes. Thousand Oaks, CA: Sage Publications; 2000.
89. Sonis ST. The pathobiology of mucositis. Semin Oncol Nurs. 2004;20(1):11-15.
90. Quinn B, Stone R, Uhlenhopp M, McCann S, Blijlevens N. Ensuring accurate oral mucositis assessment in the European Group for Blood and Marrow Transplantation Prospective Oral Mucositis Audit. Eur J Oncol Nurs. 2007;11(suppl 1):S10-S18.
91. Borbasi S, Cameron K, Quested B, Olver I, To B, Evans D. More than a sore mouth: patients' experience of oral mucositis. Oncol Nurs Forum. 2002;29(7):1051-1057.
92. Kwong KK. Prevention and treatment of oropharyngeal mucositis following cancer therapy: are there new approaches? Cancer Nurs. 2004;27(3):183-205.
93. Hymavich D. Measurement Issues with Children and Adolescents. In: Franck-Stromborg M, Olson S, eds. Instruments for Clinical Nursing Research. Boston: Jones and Bartlett Publishers International; 1997.
94. Jacobson S. Evaluating instruments for use in clinical nursing research. In: Franck-Stromborg M, Olson S, eds. Instruments for Clinical Nursing Research. Boston: Jones and Bartlett Publishers International; 1997.
95. Stone R, Fliedner MC, Smiet AC. Management of oral mucositis in patients with cancer. Eur J Oncol Nurs. 2005;9(suppl 1):S24-S32.
96. Stone R, Potting CM, Clare S, et al. Management of oral mucositis at European transplantation centres. Eur J Oncol Nurs. 2007;11(suppl 1): S3-S9.
97. Holmes S, Mountain E. Assessment of oral status: evaluation of 3 assessment guides. J Clin Nurs. 1993;2(1):35-40.
98. Hinds PS, Schum L, Srivastava DK. Is clinical relevance sometimes lost in summative scores? West J Nurs Res. 2002;24(4):345-353.
99. Nelson W, Gibson F, Hayden S, Morgan N. Using action research in paediatric oncology to develop an oral care algorithm. Eur J Oncol Nurs. 2001;5(3):180-189.
100. Tomlinson D, Gibson F, Treister N, et al. Designing an oral mucositis assessment instrument for use in children: generating items using a nominal group technique. Support Care Cancer. 2009;17(5):555-562.
101. Tomlinson D, Gibson F, Treister N, et al. Challenges of mucositis assessment in children: expert opinion. Eur J Oncol Nurs. 2008;12(5): 469-475.
102. Worthington HV, Clarkson JE, Eden OB. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev. 2007(4):CD000978.
103. Clarkson JE, Worthington HV, Eden OB. Interventions for treating oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev. 2007(2):CD001973.